Connect with others who understand.

Sign up Log in
Quick Links
Q&A Treatments A-Z Help Center Guidelines Crisis Accessibility
Resources
Diagnosis & Information Managing Your Condition Treating Ovarian Cancer All Resources
About MyOvarianCancerTeam
What is This Site Terms of Use Privacy policy
Powered By

List of Treatments for Ovarian Cancer

Below is a listing of treatments and therapies for ovarian cancer. Click on one to read more information or connect with others currently using it.

All
A-M
N-Z
Most Selected

Avastin (Bevacizumab)

Overview
Avastin is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat lung, colorectal, breast, and several other cancers. Avastin is sometimes prescribed off-label to treat ovarian… read more

Avmapki Fakzynja Co-Pack (Avutometinib/Defactinib)

Overview

Avmapki Fakzynja Co-Pack is approved by the U.S. Food and Drug Administration (FDA) for the treatment of adults with recurrent low-grade serous ovarian cancer (LGSOC) that has a mutation (change) in the KRAS gene…

 read more

Chemotherapy

Overview
Chemotherapy, or chemo, involves using drugs to kill ovarian cancer cells. Chemotherapy medications may be pills or capsules that are taken by mouth or liquids that are given intravenously (by IV).… read more

Clinical Trials

Overview
Depending on several factors, you may be eligible to participate in clinical trials studying new treatments for ovarian cancer. Clinical trials are the only way new treatments for ovarian cancer can be tested.… read more

Debulking

Overview
Debulking is a surgical treatment to remove as much cancer from the abdomen as possible. Depending on where the cancer has spread, debulking may include removing tumors throughout the belly or removing organs,… read more

Elahere (Mirvetuximab Soravtansine-Gynx)

Overview
Elahere is approved by the U.S. Food and Drug Administration (FDA) for the treatment of adults with folate receptor alpha (FRa)-positive, platinum-resistant epithelial ovarian, fallopian tube, or primary…

 read more

Exercise

Overview
Regular physical activity has been shown to benefit people with ovarian cancer in many ways. Exercise can improve quality of life during and after treatment. Being physically active helps reduce fatigue and… read more

Gemzar (Gemcitabine)

Overview
Gemzar is approved by the U.S. Food and Drug Administration (FDA) for use in combination with the chemotherapy carboplatin for the treatment of advanced ovarian cancer that has relapsed (returned) at least six…

 read more

Hysterectomy

Overview
Hysterectomy is surgery to remove the uterus, and it may be performed if ovarian cancer has spread to the uterus. In cases where a hysterectomy is used to treat ovarian cancer, oophorectomy (removal of the… read more

Intraperitoneal Chemotherapy

Overview
Intraperitoneal chemotherapy (IP therapy) is an ovarian cancer treatment. It is similar to chemotherapy in that it uses the same types of drugs, but it delivers them to the body in a different way.

Rather… read more

Lynparza (Olaparib)

Overview
Lynparza is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat deleterious germline or somatic BRCA-mutated advanced ovarian cancer who are in complete or partial response to… read more

Nutrition

Overview
Everyone feels their best when they consistently eat a healthy, balanced diet. For people with ovarian cancer, good nutrition can help you recover from treatment, reduce treatment side effects, support bone… read more

Oophorectomy

Overview
Oophorectomy is surgery to remove the ovaries. Oophorectomy may be unilateral (one ovary removed) or bilateral (both ovaries removed). During this process, the surgeon may also remove one or both fallopian… read more

Radiation Therapy

Overview
Radiation therapy typically involves aiming strong beams of radiation at cancer cells to stop them from growing or to destroy them completely. Radiation therapy is not considered a first-line treatment for… read more

Rozlytrek (Entrectinib)

Overview
Rozlytrek is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat cancerous tumors that have a neurotrophic tyrosine receptor kinase (NTRK) gene fusion without a known resistance… read more

Rubraca (Rucaparib)

Overview
Rubraca is a prescription drug approved by the U.S. Food and Drug Administration (FDA) for the maintenance treatment of adult patients with recurrent epithelial ovarian cancer who are in a complete or partial… read more

Vitrakvi (Larotrectinib)

Overview
Vitrakvi is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat solid tumors that have a neurotrophic receptor tyrosine kinase (NTRK) gene fusion without a known resistance… read more

Zejula (Niraparib)

Overview
Zejula is a prescription drug approved by the U.S. Food and Drug Administration (FDA) for the maintenance treatment of adults with advanced or recurrent epithelial ovarian cancer who are in a complete or… read more

Already a Member? Log in